Clinical trials
Recruiting Hyperkalemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| AccurKardia, Inc. | 1 |
| Karolinska Institutet | 1 |
| Mario Negri Institute for Pharmacological Research | 1 |
| Peking University First Hospital | 1 |
| Saglik Bilimleri Universitesi | 1 |
| University Medical Center Groningen | 1 |
| University of California, San Francisco | 1 |
| Vifor Pharma, Inc. | 1 |
| Waterstone Pharmaceutical (Wuhan) Co., LTD. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperkalemia | 12 |
| Renal Insufficiency, Chronic | 7 |
| Acidosis | 1 |
| Hypertension | 1 |
| Kidney Failure, Chronic | 1 |
Trials
Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.